{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:21:36Z","timestamp":1787952096779,"version":"build-2784847793"},"reference-count":23,"publisher":"Jaypee Brothers Medical Publishing","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.59556\/japi.72.0527","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T02:49:53Z","timestamp":1751942993000},"page":"61-64","source":"Crossref","is-referenced-by-count":1,"title":["A Study on Drug Prescribing Patterns in Vitiligo Patients of Andhra Pradesh in a Tertiary Care Teaching Hospital"],"prefix":"10.59556","volume":"72","author":[{"given":"Somanaboina","family":"Padmakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplab","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"issue":"(6):","key":"key20250708064945_B1","doi-asserted-by":"crossref","first-page":"473\u2013","DOI":"10.4103\/ijd.IJD_822_19","article-title":"A nationwide, multicentric case-control study on vitiligo (MEDEC-V) to elicit the magnitude and correlates.","volume":"65","author":"Sarma","year":"2020;","journal-title":"Indian J Dermatol"},{"issue":"(2):","key":"key20250708064945_B2","first-page":"65\u2013","article-title":"Pathogenesis of vitiligo: an update.","volume":"4","author":"Arora","year":"2017;","journal-title":"Pigment Int"},{"issue":"(6):","key":"key20250708064945_B3","doi-asserted-by":"crossref","first-page":"701.","DOI":"10.4103\/0378-6323.45144","article-title":"Clinical and sociodemographic study of vitiligo.","volume":"74","author":"Shah","year":"2008;","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"(9988):","key":"key20250708064945_B4","doi-asserted-by":"crossref","first-page":"74\u2013","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo.","volume":"386","author":"Ezzedine","year":"2015;","journal-title":"Lancet"},{"issue":"(6):","key":"key20250708064945_B5","doi-asserted-by":"crossref","first-page":"571\u2013","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review.","volume":"236","author":"Bergqvist","year":"2020;","journal-title":"Dermatology"},{"issue":"(10):","key":"key20250708064945_B6","doi-asserted-by":"crossref","first-page":"1369\u2013","DOI":"10.1111\/j.1468-3083.2007.02278.x","article-title":"Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.","volume":"21","author":"Brazzelli","year":"2007;","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key20250708064945_B7","first-page":"15\u2013","article-title":"Current and emerging therapy for the management of vitiligo.","volume":"2:","author":"Border\u00e9","year":"2009;","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"(6):","key":"key20250708064945_B8","doi-asserted-by":"crossref","first-page":"467\u2013","DOI":"10.1111\/j.1610-0387.2007.06280.x","article-title":"Current state of vitiligo therapy\u2013evidence-based analysis of the literature.","volume":"5","author":"Forschner","year":"2007;","journal-title":"J Dtsch Dermatol Ges"},{"issue":"(1):","key":"key20250708064945_B9","doi-asserted-by":"crossref","first-page":"52\u2013","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines.","volume":"51","author":"Grimes","year":"2004;","journal-title":"J Am Acad Dermatol"},{"key":"key20250708064945_B10","doi-asserted-by":"crossref","first-page":"37.","DOI":"10.4103\/jehp.jehp_90_18","article-title":"A prescription audit using the World Health Organization-recommended core drug use indicators in a rural hospital of Delhi.","volume":"8:","author":"Singh","year":"2019;","journal-title":"J Educ Health Promot"},{"issue":"(141):","key":"key20250708064945_B11","first-page":"241\u2013","article-title":"Drug prescribing pattern in dermatology in a teaching hospital in Western Nepal.","volume":"41","author":"Sarkar","year":"2001;","journal-title":"J Nepal Med Assoc"},{"issue":"(1):","key":"key20250708064945_B12","doi-asserted-by":"crossref","first-page":"5\u2013","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus.","volume":"168","author":"Taieb","year":"2013;","journal-title":"Br J Dermatol"},{"issue":"(5):","key":"key20250708064945_B13","first-page":"581\u2013","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.","volume":"139","author":"Lepe","year":"2003;","journal-title":"Arch Dermatol"},{"issue":"(1):","key":"key20250708064945_B14","doi-asserted-by":"crossref","first-page":"104\u2013","DOI":"10.5021\/ad.2015.27.1.104","article-title":"Triple combination of systemic corticosteroids, excimer laser, and topical tacrolimus in the treatment of recently developed localized vitiligo.","volume":"27","author":"Jang","year":"2015;","journal-title":"Ann Dermatol"},{"issue":"(2):","key":"key20250708064945_B15","doi-asserted-by":"crossref","first-page":"125\u2013","DOI":"10.1111\/j.1346-8138.2009.00774.x","article-title":"Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo.","volume":"37","author":"Lo","year":"2010;","journal-title":"J Dermatol"},{"issue":"(4):","key":"key20250708064945_B16","doi-asserted-by":"crossref","first-page":"970\u2013","DOI":"10.1038\/jid.2014.527","article-title":"Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study.","volume":"135","author":"Cavali\u00e9","year":"2015;","journal-title":"J Invest Dermatol"},{"issue":"(8):","key":"key20250708064945_B17","doi-asserted-by":"crossref","first-page":"951\u2013","DOI":"10.1111\/j.1468-3083.2009.03138.x","article-title":"Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.","volume":"23","author":"Radakovic","year":"2009;","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"(6):","key":"key20250708064945_B18","doi-asserted-by":"crossref","first-page":"498\u2013","DOI":"10.2340\/00015555-0161","article-title":"Basic fibroblast growth factor promotes melanocyte migration via increased expression of p125(FAK) on melanocytes.","volume":"86","author":"Wu","year":"2006;","journal-title":"Acta Derm Venereol"},{"issue":"(6):","key":"key20250708064945_B19","first-page":"e13109.","article-title":"Efficacy and safety of basic fibroblast growth factor (bFGF) related decapeptide solution plus tacrolimus 0.1% ointment versus tacrolimus 0.1% ointment in the treatment of stable vitiligo.","volume":"32","author":"Shah","year":"2019;","journal-title":"Dermatol Ther"},{"issue":"(3):","key":"key20250708064945_B20","doi-asserted-by":"crossref","first-page":"476\u2013","DOI":"10.1046\/j.1365-2133.2001.04381.x","article-title":"Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo.","volume":"145","author":"Ameen","year":"2001;","journal-title":"Br J Dermatol"},{"issue":"(6):","key":"key20250708064945_B21","doi-asserted-by":"crossref","first-page":"882\u2013","DOI":"10.1111\/1523-1747.ep12462151","article-title":"Stimulation of human melanocytes by vitamin D3 possibly mediates skin pigmentation after sun exposure.","volume":"90","author":"Tomita","year":"1988;","journal-title":"J Invest Dermatol"},{"issue":"(6):","key":"key20250708064945_B22","doi-asserted-by":"crossref","first-page":"750\u2013","DOI":"10.4103\/0378-6323.120720","article-title":"The role of vitamin D in melanogenesis with an emphasis on vitiligo.","volume":"79","author":"AlGhamdi","year":"2013;","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"key20250708064945_B23","doi-asserted-by":"crossref","first-page":"28\u2013","DOI":"10.1016\/j.clnesp.2016.05.006","article-title":"Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: a prospective study.","volume":"15:","author":"Karag\u00fczel","year":"2016;","journal-title":"Clin Nutr ESPEN"}],"container-title":["Journal of the Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T02:49:56Z","timestamp":1751942996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.japi.org\/article\/japi-72-5-61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.59556\/japi.72.0527"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0527","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}